Ascendiant Capital Markets
Ascendiant Capital Markets is a boutique investment bank and broker-dealer headquartered in Jupiter, Florida, offering corporate finance, M&A advisory, equity research, institutional sales and market making. Its research concentrates on healthcare and technology companies.
Activity24M
RatingsPrice targetsKey figures
- Stocks covered
- 3812M
- Actions
- 13112M
- Ratings / Price targets
- 125 / 6
- Buy-rated
- 100%of 38 rated
- Median upside
- +134.9%
- Targets raised / lowered
- 1 / 1
- On record
- Mar 2012 – Sep 2026
Overview
Here’s our simple business philosophy and formula for success – maximize relationships, not fees.
As of 2026, Ascendiant's two-analyst team covers healthcare, including biotech, life sciences and medical devices, as well as technology, energy, consumer, media and internet companies. In July 2025, it rated 54 companies, 53 of them Buy. The firm presents its equity research as coverage of client companies. It says it does not seek exclusivity or a right of first refusal after a capital raise, arguing that public companies need support from a range of investors, analysts and banks. Ascendiant has also invested its own capital; in 2019, its principals managed two in-house funds.
Bradley Wilhite and Mark Bergendahl launched the first Ascendiant entity, Ascendiant Capital Group, in 2001. They had previously founded and operated businesses including Odyssey Sports, which was later sold to Callaway Golf. The broker-dealer Ascendiant Capital Markets, LLC was organized in Nevada in 2010. Its main office is in Jupiter, Florida, with an additional office in Irvine, California.
Milestones
- 2001
First entity, Ascendiant Capital Group, launched
- 2010
Broker-dealer Ascendiant Capital Markets, LLC organized in Nevada
- 2014
Adopts three-tier Buy/Hold/Sell rating system
Firm facts
- Type
- Boutique
- Founded
- 2001
- Headquarters
- Jupiter, United States
- Director of Research
- Edward M. Woo
- Rating scale
- BuyHoldSell12 months
- Also filed as
- Ascendiant · Ascendiant Capital
- Website
- ascendiant.com
Rating methodology
Since January 31, 2014, Ascendiant has assigned 12-month ratings of Buy (expected total return of 15% or more), Hold (-15% to +15%) or Sell. This scale replaced one that also included Strong Buy and Speculative Buy.
Coverage12M
Sectors
Most covered24M
| Stock | Rating | Target |
|---|---|---|
 Duos Technologies Group, Inc.DUOT | Buy | $17 |
 Genasys Inc.GNSS | Buy | $5 |
 RenovoRx, Inc.RNXT | Buy | — |
 GRI Bio, Inc.GRI | Buy | — |
 Lucid Diagnostics Inc.LUCD | Buy | — |
 PAVmed Inc.PAVM | Buy | — |
 Quantum Computing, Inc.QUBT | Buy | $40 |
 SurgePays, Inc.SURG | Buy | $10 |
 Alzamend Neuro, Inc.ALZN | Buy | — |
 Aemetis, Inc.AMTX | Buy | — |
Most active analysts
- Edward Woo3 notesGNSSQUBTSNYR
Recent actions
| Date | Stock | Rating action | Rating | Target |
|---|---|---|---|---|
| Sep 16 | ALAllarity Therapeutics, Inc.ALLR | Reiterate | Buy | |
| Sep 14 | PABanzai International, Inc.PARA | Reiterate | Buy | |
| Sep 14 | SurgePays, Inc.SURG | Reiterate | Buy | |
| Sep 14 | Duos Technologies Group, Inc.DUOT | Reiterate | Buy | |
| Sep 14 | KSKnightscope, Inc.KSCP | Reiterate | Buy | |
| Sep 14 | NTNextTrip, Inc.NTRP | Reiterate | Buy | |
| Sep 11 | CNCerenome, Inc.CNSY | Reiterate | Buy | |
| Sep 11 | OTOutlook Therapeutics, Inc.OTLK | Reiterate | Buy | |
| Sep 11 | PDPro-Dex, Inc.PDEX | Reiterate | Buy | |
| Sep 4 | LILiqTech International, Inc.LIQT | Reiterate | Buy | |
| Aug 28 | Genasys Inc.GNSS | Reiterate | Buy | $5.50 →$5 |